Published Technical Disclosure Archive

Synergistic Combinations of Branched Amino Acid Surfactants with Emerging Technologies

Publication ID: 24-11857515_0003_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Combinations of Branched Amino Acid Surfactants with Emerging Technologies,” Published Technical Disclosure No. 24-11857515_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857515_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,515.

Summary of the Inventive Concept

The present inventive concept integrates branched amino acid surfactants with emerging technologies such as AI, IoT, blockchain, and novel nanomaterials to create synergistic combinations with enhanced surface-active properties, improved authenticity, and personalized healthcare capabilities.

Background and Problem Solved

The original patent disclosed branched surfactants for use in healthcare products, but these surfactants had limitations in terms of authenticity, trackability, and adaptability to individual health needs. The present inventive concept addresses these limitations by integrating the branched amino acid surfactants with emerging technologies to create a more powerful system.

Detailed Description of the Inventive Concept

The new inventive concept comprises a branched amino acid surfactant integrated with a blockchain-based supply chain management system to ensure authenticity and trackability of the surfactant in healthcare products. Additionally, the surfactant can be optimized using artificial intelligence algorithms to predict and adjust the molecular structure of the surfactant. The surfactant can also be combined with an Internet of Things (IoT) sensor to monitor and adjust the concentration of the surfactant in real-time. Furthermore, the surfactant can be integrated with a novel nanomaterial to create a synergistic combination with enhanced surface-active properties. The surfactant can also be integrated with a machine learning algorithm to predict and adapt the surfactant's properties to an individual's specific health needs.

Novelty and Inventive Step

The new inventive concept is novel and non-obvious because it combines the branched amino acid surfactant with emerging technologies in a way that is not suggested by the original patent. The integration of these technologies creates a synergistic combination that is more than the sum of its parts, providing enhanced surface-active properties, improved authenticity, and personalized healthcare capabilities.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include integrating the branched amino acid surfactant with other emerging technologies such as augmented reality, 5G networks, or biometrics. The surfactant could also be combined with other nanomaterials or biomaterials to create different synergistic combinations.

Potential Commercial Applications and Market

The present inventive concept has significant commercial potential in the healthcare industry, particularly in the areas of personalized medicine, pharmaceuticals, and medical devices. The integration of emerging technologies with branched amino acid surfactants could create new business opportunities and revenue streams for companies operating in these industries.

CPC Classifications

SectionClassGroup
A A61 A61K47/183
A A61 A61K9/0019
A A61 A61K9/08
A A61 A61K9/107
A A61 A61K31/5377
A A61 A61K31/55
A A61 A61K47/186
A A61 A61K47/20

Field of Art

Healthcare formulation chemistry, specifically surfactant design for pharmaceutical and medical applications, involving advanced materials science, molecular engineering, and interdisciplinary technology integration

Person of Ordinary Skill (PHOSITA) Profile

A PhD-level chemist or chemical engineer with expertise in surfactant design, pharmaceutical formulations, and emerging technologies, possessing knowledge of molecular modification techniques, supply chain technologies, and computational chemistry methods

Obviousness Rationale

A PHOSITA would recognize that integrating emerging technologies with established surfactant designs represents a predictable extension of known molecular engineering principles. The source patent's foundational work on branched amino acid surfactants provides a clear technological framework for exploring advanced integration strategies. The disclosed variations represent logical combinations of known technologies that would be apparent to a skilled practitioner seeking to enhance surfactant functionality and performance.

Obvious Combinations & Variations

Source Patent Element
Branched amino acid surfactant with surface-active properties for healthcare products
PTD Variation
Integrating surfactant with blockchain supply chain management system
Obviousness Reasoning
Applying blockchain tracking to pharmaceutical ingredients is a known technique for ensuring product authenticity, representing a predictable application of existing supply chain technologies to established molecular systems
Source Patent Element
Surfactant molecular structure with potential for modification
PTD Variation
Using artificial intelligence algorithms to predict and adjust molecular structure
Obviousness Reasoning
Computational modeling of molecular structures is a standard approach in chemical engineering, and AI-assisted molecular design represents a natural progression of existing computational chemistry techniques
Source Patent Element
Healthcare formulation with surfactants as active components
PTD Variation
Combining surfactant with IoT sensors for real-time concentration monitoring
Obviousness Reasoning
Integrating sensor technologies for real-time monitoring of pharmaceutical ingredients is a predictable extension of existing quality control and formulation management strategies
Source Patent Element
Surface-active amino acid derivatives with potential for structural modification
PTD Variation
Synergistic combination with novel nanomaterials to enhance surface-active properties
Obviousness Reasoning
Exploring material synergies through nanomaterial integration is a standard approach in materials science for enhancing fundamental molecular properties
Source Patent Element
Healthcare formulation designed for broad application
PTD Variation
Machine learning algorithm for personalizing surfactant properties
Obviousness Reasoning
Applying machine learning to personalize pharmaceutical ingredients represents a logical progression of existing computational and medical technologies
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857515 and the published technical disclosure, a person of ordinary skill in the art would find the proposed variations obvious and predictable extensions of existing surfactant design principles. The disclosed combinations represent standard technological integration strategies that would be apparent to a skilled practitioner seeking to enhance molecular functionality through interdisciplinary approaches.

Original Patent Information

Patent NumberUS 11,857,515
TitleBranched amino acid surfactants for use in healthcare products
Assignee(s)AdvanSix Resins & Chemicals LLC